NXR
This asset is not currently listed on any markets available through Pearler. The information on this page may be inaccurate or out of date.
🇦🇺 ASX
👑 Overview
📈 Performance
💵 Cost
🍃 Esg
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual capital growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
0
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Nemex Resources Limited
📈 Performance
Price History
N/A
1M
All Time
Graph
Table
Performance graph isn't available yet for this share
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in NXR
0
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in NXR
N/A
NXR investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
👶 Age of investors
18 - 25
26 - 34
35 - 90
🙋 Legal gender of investors
Female
Male
Pearlers who invest in NXR also invest in...
Want more shares? Try these...
Next Science Ltd. engages in the research, development, and distribution of technologies with bacterial issue application. The company is headquartered in Chatswood, New South Wales. The company went IPO on 2019-04-18. The firm's principal activities include development and commercialization of XBIO technology. The XBIO technology is a non-toxic technology used in solving the problems of bacterial biofilms-based infections in human health. Its XBIO technology is a non-toxic technology with efficacy in eradicating both biofilm based and free-floating bacteria. The Company’s products include XPERIENCE, Blast X, SurgX and Bactisure. The XPERIENCE product is an antimicrobial solution used to prevent surgical site infections by rinsing away debris and microorganisms. SurgX Sterile Antimicrobial Gel is used to reduce surgical site and post-surgical infections by destroying planktonic and biofilm-based bacteria within the gel with sustained effectiveness for up to five days. The Blast X is an antimicrobial wound gel.
📊 Share price
$0.58 AUD
Nexus Minerals Ltd. engages in the acquisition, exploration, and development of mineral properties. The company is headquartered in Perth, Western Australia. The company went IPO on 2007-02-23. The firm has a portfolio of gold projects in the Eastern Goldfields of Western Australia and Bethanga Porphyry Copper-Gold Project in Victoria. Its projects include Wallbrook Gold Project, Bethanga Porphyry Copper-Gold Project, Pinnacles JV Gold Project (Pinnacles JV), Pinnacles Gold Project (PGP), and Mt Celia Gold Project. The Wallbrook Gold Project consists of a contiguous package of about 250 square kilometers in the eastern goldfields of Western Australia. The Bethanga Porphyry Copper-Gold Project covers about 194 square kilometers, which is in Australia's Porphyry Copper Gold geological terrain in northeast Victoria. The Pinnacles JV is in the Eastern Goldfields of Western Australia, about 100 kilometers (km) northeast of Kalgoorlie-Boulder. The PGP covers about 125 square kilometers in Western Australia and encapsulates the Pinnacles JV Project. The Mt Celia Project is located about 180 km northeast of Kalgoorlie.
📊 Share price